Invitrogen Shares Nosedive as Q1 Outlook Dims | GenomeWeb

NEW YORK, March 1 - Shares in Invitrogen fell sharply as the company warned that first-quarter revenue and earnings will be smaller than expected due to currency-exchange rates and weakness in some of its business units.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.